Assessment of antibiotic pharmacokinetics, molecular biomarkers and clinical status in critically ill adults diagnosed with community-acquired pneumonia

Published: 8 June 2022| Version 2 | DOI: 10.17632/w7gt8zdp3r.2
Contributor:
István Vincze

Description

The protocol of a clinical study aimed at the characterization of the pharmacokinetics of piperacillin and tazobactam and its association with the concentrations of inflammatory markers and adrenal steroids during CAP therapy will be investigated in up to 40 critically ill patients.

Files

Institutions

Semmelweis Egyetem

Categories

Observational Study

Licence